Methods of treating insulin-dependent diabetes mellitus by administration of IL-10
US5827513A · kind A · utility
5Cited by
0References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 30, 1995 |
| Grant date | Oct 27, 1998 |
| Priority date | — |
| Expiry date | Mar 30, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/2066
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed is a method for treating an individual who is predisposed to develop insulin-dependent diabetes mellitus. To practice the method, an amount of interleukin-10 protein effective to maintain blood glucose levels at a non-diabetic level is administered to an individual predisposed to develop the disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.